YiChang HEC ChangJiang Pharmaceutical Co Ltd Environmental Analytics
Environmental and financial analysis dashboard for YiChang HEC ChangJiang Pharmaceutical Co Ltd. Industry: MANUFACTURING
Company Overview for YiChang HEC ChangJiang Pharmaceutical Co Ltd
Highlights
Showing data for FY2022
Operational Environmental Cost
$14m
Operational Environmental Cost Intensity
2.58%
Total Environmental Cost
N/A
Total Environmental Cost Intensity
N/A
ΔOperational Environmental Cost (2020-2022)
$5.79m
Decoupling Rate (2020-2022)
-6.97%
Adjusted EBITDA
$87m
Adjusted EBITDA Margin
16%
Environmental cost statement
Showing data for FY2022
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| OPERATIONAL SOCIAL COST OF CARBON | ||||
| -17.77% | -96.59% | 89.53% | ||
| 0.00% | 0.01% | 0.00% | 0.00% | |
| 61.62% | 6.34% | 17.05% | ||
| 2.25% | 9.10% | 2.57% | 1.83% | |
| $8m | $13m | $14m | $16m | |
| 61.53% | 6.28% | 17.05% | ||
| 2.25% | 9.10% | 2.58% | 1.83% | |
| INDIRECT SOCIAL COST OF CARBON | ||||
| N/A | N/A | N/A | ||
| N/A | N/A | N/A | N/A | |
| N/A | N/A | N/A | ||
| N/A | N/A | N/A | N/A | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. Scope 2: Social Cost of Carbon is calculated using market-based emissions data. | ||||
Environmental cost bridge
Showing data for FY2022
Integrated financial analysis
Highlights
Showing data for FY2022
Adjusted EBITDA Margin
16%
Adjusted EBIT Margin
6.00%
EV / Adjusted EBITDA
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
EV / Adjusted EBIT
Company Value: Placeholder
Industry Average: Placeholder
Coming soon
Integrated income statement
Showing data for FY2022
| USD MM | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| INCOME STATEMENT | ||||
$359m | $143m | $539m | $888m | |
| -60.07% | 275.72% | 64.75% | ||
$148m | $169m | $438m | $500m | |
| 41.34% | 117.90% | 81.35% | 56.38% | |
$211m | $-26m | $100m | $387m | |
| 58.66% | -17.90% | 18.65% | 43.62% | |
$192m | $-66m | $46m | $332m | |
| 53.43% | -46.33% | 8.57% | 37.40% | |
| ENVIRONMENTAL COST DATA | ||||
$8m | $13m | $14m | $16m | |
| 2.25% | 9.10% | 2.58% | 1.83% | |
| FINANCIAL DATA ADJUSTED FOR OPERATIONAL ENVIRONMENTAL COST | ||||
$203m | $-39m | $87m | $371m | |
| 56.41% | -27.00% | 16.07% | 41.79% | |
$184m | $-79m | $32m | $316m | |
| 51.18% | -55.43% | 6.00% | 35.57% | |
All figures are denominated in millions of USD. USD is the base currency used to monetize, other currency equivalents are calculated using end of year exchange rates. | ||||
Environmental EBITDA bridge
Showing data for FY2022
Industry benchmark
MANUFACTURE OF PHARMACEUTICAL PREPARATIONS
Scope 1 (% of Sales)
0.00%
Scope 2 (% of Sales)
2.57%
Operational Environmental Cost Intensity
2.58%
Scope 3 (% of Sales)
N/A
Total Environmental Cost Intensity
N/A
Selected peer group
Showing data for FY2022
NAME | COUNTRY | OPERATIONAL ENV. COST | OPERATIONAL ENV. COST INTENSITY |
|---|---|---|---|
YiChang HEC ChangJiang Pharmaceutical Co Ltd | CN | $14m | 2.58% |
Loading similar companies data...
Industry distribution
Showing data for FY2022
Note: Outliers are calculated using the 1.5 * IQR method, where values outside Q1 - 1.5 * IQR and Q3 + 1.5 * IQR are considered outliers.
Estimated Social Cost of Carbon Scope 3 breakdown
Percentage breakdown of Social Cost of Carbon Scope 3 into various categories
Showing data for FY2022
SCOPE 3 CATEGORY | Company (USD) | Company % | Industry Avg (USD) | Industry Avg % |
|---|---|---|---|---|
Purchased goods (1 & 2) | N/A | N/A | N/A | N/A |
Energy-related activities (3) | N/A | N/A | N/A | N/A |
Upstream transportation (4) | N/A | N/A | N/A | N/A |
Waste (5) | N/A | N/A | N/A | N/A |
Business travel (6) | N/A | N/A | N/A | N/A |
Commuting (7) | N/A | N/A | N/A | N/A |
Upstream leased assets (8) | N/A | N/A | N/A | N/A |
Downstream transportation (9) | N/A | N/A | N/A | N/A |
Processing of products (10) | N/A | N/A | N/A | N/A |
Use of products (11) | N/A | N/A | N/A | N/A |
Final treatment of products (12) | N/A | N/A | N/A | N/A |
Downstream leased assets (13) | N/A | N/A | N/A | N/A |
Franchises (14) | N/A | N/A | N/A | N/A |
Investments (15) | N/A | N/A | N/A | N/A |
Total | $0m | 100.00% | $0m | 100.00% |
Scope 3 breakdown visualization
Showing data for FY2022